secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK:        0000949858
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0000950170-25-083214
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Achieve Life Sciences shareholders reject director equity plan increase
-----------------------------------------------------------------------

- All seven director nominees elected with majority 'for' votes; broker non-votes 11,422,484.
- Ratification of PwC as auditor for FY2025 approved: 26,459,791 for, 53,879 against.
- Amendment to 2023 Non-Employee Director Equity Incentive Plan to increase shares failed: 6,736,105 for, 7,982,633 against.
- Proposal required majority of votes cast; failure may impact director compensation strategy.
- Broker non-votes (11,422,484) were not counted on non-routine matters, effectively against the plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/949858/000095017025083214/0000950170-25-083214-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/949858/000095017025083214/achv-20250604.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-083214

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer